Year: 2014
Correspondence received from Intervet International B.V. on 10 March 2014 to advise the Agency of their decision to stop the veterinary trial
Year: 2013
In accordance with Article 2.1 of Commission Regulation (EU) No. 1123/2013. International Credit Entitlement for Operators. Please be advised that this ICE Table is subject to approval by the European Commission and thus is subject to change.
Year: 2013
All documentation submitted in respect of this notification, including valid representations made by members of the public, was taken into consideration by the EPA Inspector in her report to the Board of the Agency.
Year: 2013
Inspector's Memo to Board for approval to modify condition
Year: 2013
Letter from EPA to Intervet International BV, dated 11 June 2013, with modified condition
Year: 2013
An extract from the Board Minute of the meeting of 10 June 2013,approving the modification of Condition 6.8
Representations received from members of the public in response to Intervet International BV's notification, June 2013
Year: 2013
The following valid representations were submitted in response to the notification by Intervet International BV, seeking consent to carry out a veterinary trial using a genetically modified vaccine
Year: 2013
List of non-confidential annexes received as part of Merck Sharp and Dohme/Intervet International BV's application G0493
Year: 2013
An extract from the minutes of the EPA Board Meeting of 9 April 2013, at which Intervet International BV's notification seeking consent to carry out a veterinary trial at Belmont Stud, Co Offaly, was discussed.
Year: 2013
Non-confidential application documentation for Merck Sharp and Dohme application on behalf of Intervet International BV for consent to carry out a clinical study with a GM vaccine
Year: 2013
Requests from the Agency to the notifier for additional information, and the responses received, including an amended SNIF.
Year: 2013
How to make a representation to the EPA about the proposed Deliberate Release G0493
Year: 2013
G0493-01 Consent Conditions issued to Intervet International BV on 10 April 2013 for veterinary trial using a genetically modified vaccine
Waste Management Policy in Ireland, April 2013
Year: 2013
This policy document sets out the measure through which Ireland will make the further pogress necessary to become a recycling society, with a clear focus on resource efficiency and the virtual elimination of landfilling of municipal waste. This is a Department of Environment, Community and Local Government publication.
Year: 2013
All documentation submitted in respect of this notification was taken into consideration by the EPA Inspector in her report to the Board of the Agency
Year: 2013
An extract from the minutes of the EPA Board Meeting of 25 June 2013 at which the Centre for Cellular and Molecular Therapeutics' notification seeking consent to carry out a clinical trial at St James's Hospital Dublin was discussed
Year: 2013
Environmental Risk Assessment Dossier (in accordance with Schedule II, SI 500 of 2003) for proposed Clinical Trial G0498-01
Year: 2013
Summary Notification Information Format for proposed Clinical Trial G0498-01
Year: 2013
Environmental Risk Assessment Dossier for Clinical Trial G0498-01
Year: 2013
Conclusions on the potential environmental impact from the release or the placing on the market of genetically modified organisms, re G0498-01
